What Pharma-Bio Serv Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 1 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 42,504 |
| Net activity | +0 | −42,504 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Spindel Howard | Director | Jun 09 | Other Transaction · J | −42,504 | — | — | 0 |
| Michel Kirk Wheeler | Chairman | Jan 05 | Withheld — tax / exercise cost · F | −14,340 | $1.06 | −$15.2K | 43,602 |
| Michel Kirk Wheeler | Chairman | Jan 05 | Exercise / conversion · M | +20,000 | $0.76 | +$15.2K | 57,942 |
| Spindel Howard | Director | Jan 05 | Gift · G | +1,132 | — | — | 42,504 |
| Spindel Howard | Director | Jan 05 | Gift · G | −1,132 | — | — | 0 |
| Spindel Howard | Director | Jan 05 | Withheld — tax / exercise cost · F | −18,868 | $1.06 | −$20K | 1,132 |
| Spindel Howard | Director | Jan 05 | Exercise / conversion · M | +20,000 | $1.00 | +$20K | 20,000 |
| Wiesen Irving L | Director | Mar 24 | Withheld — tax / exercise cost · F | −12,991 | $1.17 | −$15.2K | 54,250 |
| Wiesen Irving L | Director | Mar 24 | Exercise / conversion · M | +20,000 | $0.76 | +$15.2K | 67,241 |
| Wiesen Irving L | Director | Mar 24 | Withheld — tax / exercise cost · F | −17,094 | $1.17 | −$20K | 47,241 |
| Wiesen Irving L | Director | Mar 24 | Exercise / conversion · M | +20,000 | $1.00 | +$20K | 64,335 |
| Michel Kirk Wheeler | Chairman | Mar 24 | Withheld — tax / exercise cost · F | −17,094 | $1.17 | −$20K | 37,942 |
| Michel Kirk Wheeler | Chairman | Mar 24 | Exercise / conversion · M | +20,000 | $1.00 | +$20K | 55,036 |
| Perlysky Dov | Director | Mar 24 | Withheld — tax / exercise cost · F | −12,991 | $1.17 | −$15.2K | 54,203 |
| Perlysky Dov | Director | Mar 24 | Exercise / conversion · M | +20,000 | $0.76 | +$15.2K | 67,194 |
| Perlysky Dov | Director | Mar 24 | Withheld — tax / exercise cost · F | −17,094 | $1.17 | −$20K | 47,194 |
| Perlysky Dov | Director | Mar 24 | Exercise / conversion · M | +20,000 | $1.00 | +$20K | 64,288 |
| Lasanta Pedro J | Chief Financial Officer | Mar 06 | Withheld — tax / exercise cost · F | −7,167 | $1.15 | −$8.24K | 119,188 |
| Lasanta Pedro J | Chief Financial Officer | Mar 06 | Exercise / conversion · M | +8,325 | $0.99 | +$8.24K | 126,355 |
| Lasanta Pedro J | Chief Financial Officer | Mar 06 | Withheld — tax / exercise cost · F | −76,522 | $1.15 | −$88K | 118,030 |
Loading...
